Cargando…

A robust qualitative transcriptional signature for the correct pathological diagnosis of gastric cancer

BACKGROUND: Currently, pathological examination of gastroscopy biopsy specimens is the gold standard for gastric cancer (GC) diagnosis. However, it has a false-negative rate of 10–20% due to inaccurate sampling locations and/or insufficient sampling amount. A signature should be developed to aid the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yan, Haidan, Li, Meifeng, Cao, Longlong, Chen, Haifeng, Lai, Hungming, Guan, Qingzhou, Chen, Huxing, Zhou, Wenbin, Zheng, Baotong, Guo, Zheng, Zheng, Chaohui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6394047/ https://www.ncbi.nlm.nih.gov/pubmed/30819200 http://dx.doi.org/10.1186/s12967-019-1816-4

Ejemplares similares

Qualitative transcriptional signature for predicting pathological response of colorectal cancer to FOLFOX therapy
por: He, Jun, et al.
Publicado: (2019)

Quantitative or qualitative transcriptional diagnostic signatures? A case study for colorectal cancer
por: Guan, Qingzhou, et al.
Publicado: (2018)

Identification of Genes Universally Differentially Expressed in Gastric Cancer
por: Shi, Yidan, et al.
Publicado: (2021)

Robust transcriptional signatures for low-input RNA samples based on relative expression orderings
por: Liu, Huaping, et al.
Publicado: (2017)

A qualitative transcriptional signature for the early diagnosis of colorectal cancer
por: Guan, Qingzhou, et al.
Publicado: (2019)

A Qualitative Transcriptional Signature for the Risk Assessment of Precancerous Colorectal Lesions
por: Guan, Qingzhou, et al.
Publicado: (2021)

Identification of population-level differentially expressed genes in one-phenotype data
por: Xie, Jiajing, et al.
Publicado: (2020)

Identification of Common and Subtype-Specific Mutated Sub-Pathways for a Cancer
por: Yan, Haidan, et al.
Publicado: (2019)

A Qualitative Transcriptional Signature for Predicting Extreme Resistance of ER-Negative Breast Cancer to Paclitaxel, Doxorubicin, and Cyclophosphamide Neoadjuvant Chemotherapy
por: Chen, Yanhua, et al.
Publicado: (2020)

Robust transcriptional tumor signatures applicable to both formalin-fixed paraffin-embedded and fresh-frozen samples
por: Chen, Rou, et al.
Publicado: (2016)

Tamoxifen therapy benefit predictive signature coupled with prognostic signature of post-operative recurrent risk for early stage ER+ breast cancer
por: Cai, Hao, et al.
Publicado: (2015)

A Qualitative Transcriptional Signature for Predicting Recurrence Risk of Stage I–III Bladder Cancer Patients After Surgical Resection
por: Li, Yawei, et al.
Publicado: (2019)

Differential expression analysis for individual cancer samples based on robust within-sample relative gene expression orderings across multiple profiling platforms
por: Guan, Qingzhou, et al.
Publicado: (2016)

The Effects of Age, Cigarette Smoking, Sex, and Race on the Qualitative Characteristics of Lung Transcriptome
por: Guan, Qingzhou, et al.
Publicado: (2020)

An individualized prognostic signature and multi-omics distinction for early stage hepatocellular carcinoma patients with surgical resection
por: Ao, Lu, et al.
Publicado: (2016)

A qualitative signature for early diagnosis of hepatocellular carcinoma based on relative expression orderings
por: Ao, Lu, et al.
Publicado: (2018)

Two novel qualitative transcriptional signatures robustly applicable to non‐research‐oriented colorectal cancer samples with low‐quality RNA
por: Cheng, Jun, et al.
Publicado: (2021)

Qualitative Transcriptional Signature for the Pathological Diagnosis of Pancreatic Cancer
por: Zhou, Yu-Jie, et al.
Publicado: (2020)

Identification and characterization of genes with absolute mRNA abundances changes in tumor cells with varied transcriptome sizes
por: Cai, Hao, et al.
Publicado: (2019)

A qualitative transcriptional signature to reclassify histological grade of ER-positive breast cancer patients
por: Li, Jing, et al.
Publicado: (2020)

Statistically controlled identification of differentially expressed genes in one-to-one cell line comparisons of the CMAP database for drug repositioning
por: He, Jun, et al.
Publicado: (2017)

An individualized prognostic signature for gastric cancer patients treated with 5-Fluorouracil-based chemotherapy and distinct multi-omics characteristics of prognostic groups
por: Li, Xiangyu, et al.
Publicado: (2016)

Identification of reproducible drug-resistance-related dysregulated genes in small-scale cancer cell line experiments
por: Ao, Lu, et al.
Publicado: (2015)

Biased Influences of Low Tumor Purity on Mutation Detection in Cancer
por: Cheng, Jun, et al.
Publicado: (2020)

A qualitative transcriptional signature for the histological reclassification of lung squamous cell carcinomas and adenocarcinomas
por: Li, Xin, et al.
Publicado: (2019)

Individualized analysis reveals CpG sites with methylation aberrations in almost all lung adenocarcinoma tissues
por: Yan, Haidan, et al.
Publicado: (2017)

Identifying clinically relevant drug resistance genes in drug-induced resistant cancer cell lines and post- chemotherapy tissues
por: Tong, Mengsha, et al.
Publicado: (2015)

Circumvent the uncertainty in the applications of transcriptional signatures to tumor tissues sampled from different tumor sites
por: Cheng, Jun, et al.
Publicado: (2017)

Reappraise role of lymph node status in patterns of recurrence following curative resection of gastric adenocarcinoma
por: Tang, Yihui, et al.
Publicado: (2021)

A Novel Insight Into Fecal Occult Blood Test for the Management of Gastric Cancer: Complication, Survival, and Chemotherapy Benefit After R0 Resection
por: Lu, Jun, et al.
Publicado: (2021)

Transcriptional Signatures of Hippocampal Tau Pathology in Primary Age-Related Tauopathy and Alzheimer’s Disease
por: Stein-O’Brien, Genevieve L, et al.
Publicado: (2023)

Identifying CpG sites with different differential methylation frequencies in colorectal cancer tissues based on individualized differential methylation analysis
por: Yan, Haidan, et al.
Publicado: (2017)

Identification of Tamoxifen-Resistant Breast Cancer Cell Lines and Drug Response Signature
por: Guan, Qingzhou, et al.
Publicado: (2020)

Discriminating cancer-related and cancer-unrelated chemoradiation-response genes for locally advanced rectal cancers
por: Guo, You, et al.
Publicado: (2016)

GeneExpressScore Signature: a robust prognostic and predictive classifier in gastric cancer
por: Zhu, Xiaoqiang, et al.
Publicado: (2018)

Evaluation of public cancer datasets and signatures identifies TP53 mutant signatures with robust prognostic and predictive value
por: Lehmann, Brian David, et al.
Publicado: (2015)

Identifying Reproducible Molecular Biomarkers for Gastric Cancer Metastasis with the Aid of Recurrence Information
por: Li, Mengyao, et al.
Publicado: (2016)

Development and Validation of a Robust Immune-Related Prognostic Signature for Gastric Cancer
por: Huo, Junyu, et al.
Publicado: (2021)

The prediction of survival in Gastric Cancer based on a Robust 13-Gene Signature
por: Wang, Guoguang, et al.
Publicado: (2021)

A Robust Prognostic Gene Signature Based on eRNAs-Driven Genes in Prostate Cancer
por: Fan, Shuaishuai, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_0nn1fqm9r6gocomndpeihb9pob